Carmot is a biotechnology company that researches and commercializes novel therapeutics for patients with cancer and metabolic disorders. Read more
Reata is Carmot's biggest rival. Reata was founded in Plano, Texas} in 2002. Like Carmot, Reata also competes in the Biotechnology sector. Compared to Carmot, Reata generates $5.2M more revenue.
Gelesis is Carmot's #2 rival. Gelesis's headquarters is in Boston, Massachusetts, and was founded in 2006. Like Carmot, Gelesis also competes in the Biotechnology space. Gelesis generates 467% of Carmot's revenue.
No recent acquisitions found related to Carmot
Since Carmot was founded in 2008, it has participated in 4 rounds of funding. In total Carmot has raised $62.5M. Carmot's last funding round was on Sep 2020 for a total of $47.0M
No recent investments found related to Carmot